Norges Bank Takes $25.77 Million Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Norges Bank bought a new position in Surgery Partners, Inc. (NASDAQ:SGRYFree Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 805,396 shares of the company’s stock, valued at approximately $25,765,000. Norges Bank owned about 0.64% of Surgery Partners at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in SGRY. Wellington Management Group LLP boosted its stake in shares of Surgery Partners by 23.2% in the 3rd quarter. Wellington Management Group LLP now owns 8,022,700 shares of the company’s stock worth $234,664,000 after buying an additional 1,511,396 shares during the last quarter. Deerfield Management Company L.P. Series C bought a new position in Surgery Partners in the third quarter valued at about $42,705,000. Invesco Ltd. boosted its position in Surgery Partners by 9.3% in the third quarter. Invesco Ltd. now owns 3,604,357 shares of the company’s stock worth $105,427,000 after purchasing an additional 305,216 shares during the last quarter. Barclays PLC grew its stake in shares of Surgery Partners by 204.9% during the 3rd quarter. Barclays PLC now owns 289,663 shares of the company’s stock valued at $8,472,000 after purchasing an additional 194,658 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in shares of Surgery Partners by 8.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,840,212 shares of the company’s stock valued at $58,870,000 after purchasing an additional 149,146 shares during the last quarter.

Surgery Partners Trading Up 1.2 %

SGRY stock opened at $27.60 on Friday. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.71 and a quick ratio of 1.56. Surgery Partners, Inc. has a 1-year low of $22.05 and a 1-year high of $45.79. The business has a 50 day simple moving average of $26.30 and a two-hundred day simple moving average of $29.94. The company has a market capitalization of $3.51 billion, a price-to-earnings ratio of 32.09, a PEG ratio of 2.18 and a beta of 2.75.

Surgery Partners (NASDAQ:SGRYGet Free Report) last released its earnings results on Tuesday, May 7th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.04 by $0.02. The firm had revenue of $717.40 million for the quarter, compared to the consensus estimate of $707.66 million. Surgery Partners had a net margin of 0.02% and a return on equity of 3.65%. Research analysts anticipate that Surgery Partners, Inc. will post 0.84 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Jason Eric Evans sold 4,840 shares of Surgery Partners stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $29.71, for a total value of $143,796.40. Following the sale, the chief executive officer now directly owns 459,670 shares of the company’s stock, valued at $13,656,795.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 2.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. Barclays began coverage on shares of Surgery Partners in a research report on Wednesday, March 6th. They set an “equal weight” rating and a $35.00 target price for the company. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $43.00 target price on shares of Surgery Partners in a report on Wednesday, April 10th. Royal Bank of Canada reissued an “outperform” rating and set a $49.00 price target on shares of Surgery Partners in a report on Thursday, February 29th. Citigroup decreased their price objective on Surgery Partners from $42.00 to $38.00 and set a “buy” rating on the stock in a research note on Wednesday, May 8th. Finally, Benchmark reaffirmed a “buy” rating and set a $50.00 price target on shares of Surgery Partners in a report on Wednesday, May 1st. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $43.13.

Get Our Latest Research Report on Surgery Partners

About Surgery Partners

(Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

See Also

Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRYFree Report).

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.